These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 20851342)
1. Halogen bonds form the basis for selective P-TEFb inhibition by DRB. Baumli S; Endicott JA; Johnson LN Chem Biol; 2010 Sep; 17(9):931-6. PubMed ID: 20851342 [TBL] [Abstract][Full Text] [Related]
2. Comparative structural and functional studies of 4-(thiazol-5-yl)-2-(phenylamino)pyrimidine-5-carbonitrile CDK9 inhibitors suggest the basis for isotype selectivity. Hole AJ; Baumli S; Shao H; Shi S; Huang S; Pepper C; Fischer PM; Wang S; Endicott JA; Noble ME J Med Chem; 2013 Feb; 56(3):660-70. PubMed ID: 23252711 [TBL] [Abstract][Full Text] [Related]
3. The CDK9 tail determines the reaction pathway of positive transcription elongation factor b. Baumli S; Hole AJ; Wang LZ; Noble ME; Endicott JA Structure; 2012 Oct; 20(10):1788-95. PubMed ID: 22959624 [TBL] [Abstract][Full Text] [Related]
4. Cyclin-dependent kinase 9 is required for tumor necrosis factor-alpha-stimulated matrix metalloproteinase-9 expression in human lung adenocarcinoma cells. Shan B; Zhuo Y; Chin D; Morris CA; Morris GF; Lasky JA J Biol Chem; 2005 Jan; 280(2):1103-11. PubMed ID: 15528190 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of cdk9 during herpes simplex virus 1 infection impedes viral transcription. Ou M; Sandri-Goldin RM PLoS One; 2013; 8(10):e79007. PubMed ID: 24205359 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex. Biglione S; Byers SA; Price JP; Nguyen VT; Bensaude O; Price DH; Maury W Retrovirology; 2007 Jul; 4():47. PubMed ID: 17625008 [TBL] [Abstract][Full Text] [Related]
7. The CDK9 C-helix exhibits conformational plasticity that may explain the selectivity of CAN508. Baumli S; Hole AJ; Noble ME; Endicott JA ACS Chem Biol; 2012 May; 7(5):811-6. PubMed ID: 22292676 [TBL] [Abstract][Full Text] [Related]
8. CDK9 and SPT5 proteins are specifically required for expression of herpes simplex virus 1 replication-dependent late genes. Zhao Z; Tang KW; Muylaert I; Samuelsson T; Elias P J Biol Chem; 2017 Sep; 292(37):15489-15500. PubMed ID: 28743741 [TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis. Iankova I; Petersen RK; Annicotte JS; Chavey C; Hansen JB; Kratchmarova I; Sarruf D; Benkirane M; Kristiansen K; Fajas L Mol Endocrinol; 2006 Jul; 20(7):1494-505. PubMed ID: 16484339 [TBL] [Abstract][Full Text] [Related]
10. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes. Dow EC; Liu H; Rice AP J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073 [TBL] [Abstract][Full Text] [Related]
11. Role of cdk9 in the optimization of expression of the genes regulated by ICP22 of herpes simplex virus 1. Durand LO; Roizman B J Virol; 2008 Nov; 82(21):10591-9. PubMed ID: 18753202 [TBL] [Abstract][Full Text] [Related]
12. Phenyl-1-Pyridin-2yl-ethanone-based iron chelators increase IκB-α expression, modulate CDK2 and CDK9 activities, and inhibit HIV-1 transcription. Kumari N; Iordanskiy S; Kovalskyy D; Breuer D; Niu X; Lin X; Xu M; Gavrilenko K; Kashanchi F; Dhawan S; Nekhai S Antimicrob Agents Chemother; 2014 Nov; 58(11):6558-71. PubMed ID: 25155598 [TBL] [Abstract][Full Text] [Related]
13. Discovery of novel CDK inhibitors via scaffold hopping from CAN508. Jing L; Tang Y; Xiao Z Bioorg Med Chem Lett; 2018 May; 28(8):1386-1391. PubMed ID: 29550093 [TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase 9 forms a complex with GATA4 and is involved in the differentiation of mouse ES cells into cardiomyocytes. Kaichi S; Takaya T; Morimoto T; Sunagawa Y; Kawamura T; Ono K; Shimatsu A; Baba S; Heike T; Nakahata T; Hasegawa K J Cell Physiol; 2011 Jan; 226(1):248-54. PubMed ID: 20665673 [TBL] [Abstract][Full Text] [Related]
15. Characterization of molecular and cellular functions of the cyclin-dependent kinase CDK9 using a novel specific inhibitor. Albert TK; Rigault C; Eickhoff J; Baumgart K; Antrecht C; Klebl B; Mittler G; Meisterernst M Br J Pharmacol; 2014 Jan; 171(1):55-68. PubMed ID: 24102143 [TBL] [Abstract][Full Text] [Related]
16. Mechanism of H-8 inhibition of cyclin-dependent kinase 9: study using inhibitor-immobilized matrices. Shima D; Yugami M; Tatsuno M; Wada T; Yamaguchi Y; Handa H Genes Cells; 2003 Mar; 8(3):215-23. PubMed ID: 12622719 [TBL] [Abstract][Full Text] [Related]
17. Novel, selective CDK9 inhibitors for the treatment of HIV infection. Németh G; Varga Z; Greff Z; Bencze G; Sipos A; Szántai-Kis C; Baska F; Gyuris A; Kelemenics K; Szathmáry Z; Minárovits J; Kéri G; Orfi L Curr Med Chem; 2011; 18(3):342-58. PubMed ID: 21143121 [TBL] [Abstract][Full Text] [Related]
18. CDK9: a signaling hub for transcriptional control. Bacon CW; D'Orso I Transcription; 2019 Apr; 10(2):57-75. PubMed ID: 30227759 [TBL] [Abstract][Full Text] [Related]
19. CDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90. Breuer D; Kotelkin A; Ammosova T; Kumari N; Ivanov A; Ilatovskiy AV; Beullens M; Roane PR; Bollen M; Petukhov MG; Kashanchi F; Nekhai S Retrovirology; 2012 Nov; 9():94. PubMed ID: 23140174 [TBL] [Abstract][Full Text] [Related]
20. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation. Baumli S; Lolli G; Lowe ED; Troiani S; Rusconi L; Bullock AN; Debreczeni JE; Knapp S; Johnson LN EMBO J; 2008 Jul; 27(13):1907-18. PubMed ID: 18566585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]